Therapeutic approaches for corneal neovascularization

被引:0
作者
Sepehr Feizi
Amir A. Azari
Sharareh Safapour
机构
[1] Shahid Beheshti University of Medical Sciences,Ophthalmic Research Center, Labbafinejad Medical Center
来源
Eye and Vision | / 4卷
关键词
Corneal neovascularization; Angiogenesis; Angiogenic therapies;
D O I
暂无
中图分类号
学科分类号
摘要
Angiogenesis refers to new blood vessels that originate from pre-existing vascular structures. Corneal neovascularization which can lead to compromised visual acuity occurs in a wide variety of corneal pathologies. A large subset of measures has been advocated to prevent and/or treat corneal neovascularization with varying degrees of success. These approaches include topical corticosteroid administration, laser treatment, cautery, and fine needle diathermy. Since the imbalance between proangiogenic agents and antiangiogenic agents primarily mediate the process of corneal neovascularization, recent therapies are intended to disrupt the different steps in the synthesis and actions of proangiogenic factors. These approaches, however, are only partially effective and may lead to several side effects. The aim of this article is to review the most relevant treatments for corneal neovascularization available so far.
引用
收藏
相关论文
共 525 条
  • [11] Strömblad S(2007)Epidemiology and risk factors for corneal graft rejection Transplant Proc 39 2609-2611
  • [12] Cheresh DA(2017)Kinetics of Angiogenic Responses in Corneal Transplantation Cornea. 36 491-6
  • [13] Lee HS(2003)Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology Cornea 22 273-281
  • [14] Chung SK(2002)Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin Invest Ophthalmol Vis Sci 43 2127-2135
  • [15] Roodhooft JM(2001)The critical role of lymph nodes in corneal alloimmunization and graft rejection Invest Ophthalmol Vis Sci 42 1293-1298
  • [16] Roth HW(2002)Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk corneal transplantation Cornea 21 405-409
  • [17] Bachmann B(2012)Corneal neovascularization: an anti-VEGF therapy review Surv Ophthalmol 57 415-429
  • [18] Taylor RS(2016)Proangiogenic Interactions of Vascular Endothelial MMP14 With VEGF Receptor 1 in VEGFA-Mediated Corneal Angiogenesis Invest Ophthalmol Vis Sci. 57 3313-22
  • [19] Cursiefen C(1999)Vascular endothelial growth factor (VEGF) and its receptors FASEB J 13 9-22
  • [20] Huang PT(2014)VEGF-VEGFR Signals in Health and Disease Biomol Ther (Seoul) 22 1-9